Latest 20-F annual reports

NASDAQ
VS Media Holdings Limited's FY2024 results show a slight revenue increase but a significant net loss, raising concerns about its ability to continue as a going concern.
NYSE
Full Truck Alliance Co. Ltd. amends and restates its equity interest pledge agreement to clarify rights and obligations following a share transfer.
NASDAQ
Futu Holdings' 20-F filing reveals robust growth in 2024 despite regulatory inquiries, with increased revenues and a growing client base.
Dada Nexus Limited's 20-F filing for 2024 emphasizes its VIE structure, regulatory risks in China, and a pending merger agreement.
NASDAQ
Grifols SA's 2024 20-F filing outlines the company's financial results, strategic initiatives, and risk factors, including a restatement of comparative figures due to accounting errors.
NYSE
Tsakos Energy Navigation Limited releases its 20-F filing, detailing financial performance for the fiscal year ended December 31, 2024, and outlining various operational and strategic activities.
NASDAQ
Nano Labs Ltd's 2024 annual report reveals a company navigating the volatile cryptocurrency market and evolving regulatory landscape in China, with a focus on Web 3.0 infrastructure and product solutions.
NASDAQ
Biodexa Pharmaceuticals PLC reports its financial results for the year ended December 31, 2024, highlighting ongoing development efforts and strategic financial activities.
NASDAQ
Trip.com Group Limited details the indenture for its US$1.5 billion convertible senior notes due in 2029, outlining terms for conversion, repurchase, and redemption.
NYSE
ATRenew Inc. releases its 20-F annual report, detailing its financial results for the year ended December 31, 2024, and outlining key aspects of its business, risk factors, and corporate governance.
CureVac restructures its collaboration with GSK into a licensing agreement, granting GSK full control over influenza and COVID-19 vaccine development while CureVac focuses on oncology and other areas.
NASDAQ
Origin Agritech Limited reports a revenue increase for fiscal year 2024 but acknowledges a 'going concern' qualification due to working capital deficit and accumulated losses.
NASDAQ
HomesToLife Ltd files an amendment to its 20-F annual report to correct typographical errors and update information regarding directors.
NYSE
Auna S.A. files its annual report on Form 20-F, detailing its financial performance and operational activities for the fiscal year ended December 31, 2024.
NYSE
Southeast Airport Group's FY24 results show an increase in passenger traffic and a corresponding rise in revenue, driven by improvements in both aeronautical and non-aeronautical services.
NASDAQ
United Maritime Corporation files its 20-F, detailing its operations and financial performance for the year ended December 31, 2024, highlighting both industry-related and company-specific risks.
NYSE
Dynagas LNG Partners LP files its annual report for the fiscal year ended December 31, 2024, detailing financial performance and key developments.
NASDAQ
Kanzhun Limited files its 20-F, highlighting financial performance, VIE structure, and regulatory challenges in China.
NASDAQ
Infobird Co., Ltd releases its 20-F filing, outlining its financial results for the fiscal year 2024 and highlighting strategic shifts including acquisitions and divestitures.
NASDAQ
RedHill Biopharma releases its 20-F filing, highlighting financial results for the year ended December 31, 2024, and discussing strategic business transactions.
NASDAQ
Opera Limited's FY2024 results show a 21% increase in revenue, but a material weakness in internal control over financial reporting is noted.
NASDAQ
ATA Creativity Global's latest 20-F filing highlights its financial results for the year ended December 31, 2024, and provides an overview of its business, corporate structure, and the regulatory environment in which it operates.
NASDAQ
Li Auto's 20-F filing highlights its 2024 financial results and provides insights into its business operations and risk factors.
NYSE
América Móvil amends its 20-F/A filing after identifying material weaknesses in internal controls related to its Mexican business, leading to a restatement of management's assessment and auditor's opinion.
NYSE
Coca-Cola FEMSA reports its financial results for the year ended December 31, 2024, showcasing its performance across Mexico, Central America, and South America.
Brookfield Business Partners L.P. releases its annual report on Form 20-F, detailing its financial performance for the fiscal year ended December 31, 2024.
NASDAQ
COSCIENS Biopharma Inc. reports its annual results, highlighting a strategic shift towards natural-based products while addressing material weaknesses in internal financial controls.
NASDAQ
MMTEC, INC. reports a substantial net loss for 2024, driven by credit losses on notes receivable, while navigating strategic shifts including the sale of Alpha Mind and changes in regulatory landscapes.
NYSE
CMB.TECH NV's 20-F filing highlights a strategic pivot towards diversified and decarbonized maritime operations, alongside key financial metrics and risk assessments for the fiscal year 2024.
NYSE
Lifezone Metals Limited reports its financial results and operational activities for the year ended December 31, 2024, highlighting progress in the Kabanga Nickel Project and PGM recycling partnership.